Disease/Infection News

RSS

FDA continues to take action in the ongoing response to COVID-19 pandemic

The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic

28 Aug 2020

COVID-19 can serve as catalyst for digital innovation in healthcare

COVID-19 has upended essentially every sector of the economy, and none more so than healthcare. Healthcare leaders from across the United States share their experiences with disruption and innovation in responding to the COVID-19 crisis in the Fall 2020 issue of Frontiers of Health Services Management, a publication of the American College of Healthcare Executives (ACHE).

28 Aug 2020

FDA grants Abbott's COVID-19 rapid antigen test emergency-use authorization

Now, the U.S. Food and Drug Administration has granted emergency-use authorization to Abbott Laboratories for a $5 rapid-response COVID-19 antigen test, called BinaxNOW COVID-19 Ag Card, which is roughly the size of a credit card.

27 Aug 2020

Blood thinners help reduce the risk of COVID-19 deaths, study finds

Now, a new study by a team of researchers at the Mount Sinai Health System in New York has shown that blood thinners may reduce the risk of death by up to 50 percent among severely ill hospitalized COVID-19 patients.

27 Aug 2020

New low-cost COVID-19 test quickly delivers accurate results

A new low-cost diagnostic test for coronavirus disease 2019 (COVID-19) quickly delivers accurate results without the need for sophisticated equipment, according to a study published August 27 2020 in the open-access journal PLOS Pathogens by Teng Xu of the Vision Medicals Center for Infectious Diseases, Tieying Hou of the Guangdong Academy of Medical Sciences, Bing Gu of the Affiliated Hospital of Xuzhou Medical University, Jianwei Wang of the Chinese Academy of Medical Sciences and Peking Union Medical College, and colleagues.

27 Aug 2020

Mouse-adapted SARS-CoV-2 model helps advance the development of COVID-19 vaccines

A new COVID-19 mouse model developed at the University of North Carolina at Chapel Hill captures many of the features of human disease and has helped advance a COVID-19 vaccine candidate to clinical trial.

27 Aug 2020

Study shows furin cleavage site is crucial for SARS-CoV-2 replication

In a recent bioRxiv* preprint paper, researchers from the United States demonstrate the pivotal role the furin cleavage site insertion in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike glycoprotein plays in viral replication and pathogenesis – highlighting, in turn, the need for mutation monitoring when developing therapeutics and vaccines.

27 Aug 2020

Evidence of SARS-CoV-2 coronavirus particles in heart tissue

Researchers in Milan, Italy, have identified the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the heart tissue of deceased coronavirus disease 2019 (COVID-19) patients who had died from respiratory failure, without showing any signs of cardiac involvement.

27 Aug 2020

N95 respirators designed for single use can be decontaminated effectively

N95 respirators, which are widely worn by health care workers treating patients with COVID-19 and are designed to be used only once, can be decontaminated effectively and used up to three times, according to research by UCLA scientists and colleagues.

27 Aug 2020

Study: Estrogen may reduce severity of COVID-19 symptoms in women

Why are men at greater risk than women for more severe symptoms and worse outcomes from COVID-19 regardless of age?

27 Aug 2020

5 things to know about convalescent blood plasma

President Donald Trump told the American people this week that convalescent plasma is a potential new treatment for COVID-19.

27 Aug 2020

Two viral gene targets needed in SARS-CoV-2 detection by PCR, say researchers

Researchers at the Chan Zuckerberg Biohub, San Francisco, and collaborators have warned against only targeting one viral gene when carrying out reverse transcriptase-polymerase chain reaction (RT-PCR) testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

27 Aug 2020

First lethal mouse model of SARS-CoV-2 developed

Army scientists have developed the first lethal mouse model of SARS-CoV-2, the virus that causes COVID-19, using mice that were genetically engineered to express the human ACE2 gene--a key mechanism by which the virus enters human cells.

27 Aug 2020

NIAID awards $17 million to establish the Centers for Research in Emerging Infectious Diseases

The National Institute of Allergy and Infectious Diseases, one of the National Institutes of Health, today announced that it has awarded 11 grants with a total first-year value of approximately $17 million to establish the Centers for Research in Emerging Infectious Diseases.

27 Aug 2020

Artificial intelligence could help identify infants with low risk of bacterial infection

Artificial intelligence, or "supervised machine learning," could help identify which well-appearing infants with fever, who are 60 days old or younger, are at low risk for a serious bacterial infection, according to a study published in Pediatrics.

27 Aug 2020

NPS MedicineWise offers information to prevent hay fever symptoms

For hay fever sufferers, spring means sneezing, itchy eyes and a runny nose. Medicines can bring some relief to these symptoms, and some medicines can help prevent the symptoms if taken regularly.

27 Aug 2020

Patients from BAME communities are underrepresented in HIV research

People with HIV from BAME communities, women and heterosexual men are underrepresented in HIV studies – according to new research from the University of East Anglia and Western Sydney University.

27 Aug 2020

Scientists say insect repellent kills the SARS-CoV-2 coronavirus on surfaces

Now, a team of scientists at Britain's Defence Science and Technology Laboratory (DSTL) has shared preliminary findings of their research, showing that a product in insect repellent can kill the SARS-CoV-2 virus.

27 Aug 2020

Anticoagulation therapy associated with improved survival among COVID-19 patients

Early in the COVID-19 pandemic, Mount Sinai researchers were among the first to show that anticoagulation therapy was associated with improved survival among hospitalized COVID-19 patients

27 Aug 2020

Coronavirus can spread through drain pipes in bathrooms, study suggests

Now, a new study reveals that the virus may spread via aerosols through drain pipes in bathrooms, after scientists examined an abandoned apartment in Guangzhou, China. The findings add to the body of evidence suggesting the virus is transmissible via aerosols.

27 Aug 2020